Lanadelumab-flyo 150MG/ML INJ, syringe,2ML (TAKHZYRO)
Ended Awarded Last action
- Contract number
- 36C26024F0417
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $221,342
Award facts
- Contract value 100% obligated
- $221,342.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order contract to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for LANADELUMAB-FLYO 150MG/ML INJ, SYRINGE,2ML (TAKHZYRO). The $221,342.40 firm fixed-price contract is issued against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. This specialized pharmaceutical product is used to treat hereditary angioedema, a rare and potentially life-threatening genetic condition. As the prime contractor, Takeda will leverage its global infrastructure to deliver the contracted treatment to VA facilities nationwide. The contract has no set-aside designation and aims to ensure reliable supply chain access to this vital therapy for eligible VA patients over the next three years.
Quick answers
Who was awarded contract 36C26024F0417?
36C26024F0417 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on May 20, 2024.
How much is contract 36C26024F0417 worth?
The government has obligated $221,342 on 36C26024F0417.
Is contract 36C26024F0417 an order under another contract?
Yes. 36C26024F0417 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0417 competed?
The extent of competition for 36C26024F0417 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award